Resolution of post-trauma conjunctival inclusion cyst using 0.5% timolol maleate eyedrops. [PDF]
Antunes-Foschini R, Alves LF.
europepmc +1 more source
Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas. [PDF]
Mazhar A +3 more
europepmc +1 more source
Application of Tablet in Tablet technique to design and characterize immediate and modified release tablets of Timolol maleate. [PDF]
Gaikwad SS, Kshirsagar SJ.
europepmc +1 more source
Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection. [PDF]
Lavik E +5 more
europepmc +1 more source
Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5. [PDF]
Sipkova Z +4 more
europepmc +1 more source
Machine learning-driven drug repurposing for HER2-positive breast cancer. [PDF]
Dinesh BGH +8 more
europepmc +1 more source
Topical Timolol Beyond Infancy: A Retrospective Study of Its Use in Persistent Infantile Hemangiomas. [PDF]
Bogomolets O, Bogomolets-Sheremetieva S.
europepmc +1 more source
The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies. [PDF]
Radcliffe NM.
europepmc +1 more source

